Dapivirine vaginal ring sharply reduces HIV infection risk

DURBAN, SOUTH AFRICA – Women who consistently used a monthly vaginal ring containing the antiretroviral drug dapivirine reduced their risk of acquiring HIV infection by 75%-91% in exploratory...

Source: Ob.Gyn. News - July 20, 2016 Category: OBGYN Source Type: research